PDT Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.23M | Buy |
41,605
+23,200
| +126% | +$2.92M | 0.3% | 96 |
|
|
2025
Q1 | $2.04M | Sell |
18,405
-16,343
| -47% | -$1.81M | 0.14% | 247 |
|
|
2024
Q4 | $4.74M | Buy |
34,748
+19,848
| +133% | +$2.71M | 0.42% | 39 |
|
|
2024
Q3 | $1.72M | Buy |
+14,900
| New | +$1.72M | 0.15% | 249 |
|
|
2023
Q4 | – | Sell |
-9,306
| Closed | -$1.05M | – | 630 |
|
|
2023
Q3 | $1.05M | Sell |
9,306
-1,206
| -11% | -$136K | 0.13% | 273 |
|
|
2023
Q2 | $991K | Buy |
+10,512
| New | +$991K | 0.14% | 250 |
|
|
2022
Q4 | – | Sell |
-8,255
| Closed | -$877K | – | 803 |
|
|
2022
Q3 | $877K | Buy |
+8,255
| New | +$877K | 0.13% | 258 |
|
|
2015
Q4 | – | Sell |
-48,088
| Closed | -$1.91M | – | 749 |
|
|
2015
Q3 | $1.91M | Sell |
48,088
-400
| -0.8% | -$15.9K | 0.04% | 475 |
|
|
2015
Q2 | $2.32M | Buy |
48,488
+36,975
| +321% | +$1.77M | 0.06% | 380 |
|
|
2015
Q1 | $457K | Buy |
+11,513
| New | +$457K | 0.01% | 1048 |
|
|
2013
Q3 | – | Sell |
-23,788
| Closed | -$318K | – | 1639 |
|
|
2013
Q2 | $318K | Buy |
+23,788
| New | +$318K | 0.01% | 1238 |
|